The common cold sore virus, herpes simplex virus type 1 (HSV-1), may do more than just cause painful sores—it can invade the ...

Net product revenue of $83.8 million in 3Q and $250.1 million since launch in August 2023JNDA for B-VEC filed and on track for commercial ...

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine ...

Chardan Capital analyst Geulah Livshits has reiterated their bullish stance on KRYS stock, giving a Buy rating yesterday. Geulah Livshits has ...

November 4, 2024Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank you for standing by and welcome to Krystal Biotech's Third Quarter ...

Thank you for standing by and welcome to Krystal Biotech's third-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to hand ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...